key: cord-1007405-uzatnpng
authors: Peters, Frederik; Marschall, Ursula; Behrendt, Christian-Alexander
title: Research Letter: Prevalence of COVID-19 risk factors and risks for severe acute respiratory disease markedly higher in patients with symptomatic peripheral arterial occlusive disease
date: 2021-03-05
journal: Eur J Vasc Endovasc Surg
DOI: 10.1016/j.ejvs.2021.02.055
sha: 6a1cadf81b56b8e1aea6f2797f8abbe9e1734036
doc_id: 1007405
cord_uid: uzatnpng

nan

differences in screening and treatment patterns, COVID-19 vaccines are currently being 23 divided up between countries. The first vaccination programmes started with heartening 24 short-term results, and it appears likely that the global community will need to decide which 25 populations at risk should be immunised first.

The most vulnerable cohort with high risk of severe illness was recently described by 27 various publications. 1 Males, octogenarians, patients with cardiovascular disease, diabetes, 28 chronic liver disease, chronic renal disease, chronic pulmonary disease, malignancy, and 29 those with obesity and smoking are at higher risk when compared to the healthy population.

Patients suffering from symptomatic peripheral arterial occlusive disease (PAOD) are 31 known to suffer from chronic complex multimorbidity including all these risk factors. 2 32 Until more specific knowledge and better data on COVID-19 become available, comparable 33 diseases such as influenza and severe acute respiratory syndrome or generally acute 34 respiratory disease may serve as proxies for the vulnerability of a certain subgroup. risk factors and vulnerability for severe illness. This study aims to precisely quantify the 37 COVID-19-related risk profile and the risk for in-hospital stay with influenza, acute 38 respiratory distress syndrome (ARDS) or acute respiratory disease of patients with 39 symptomatic PAOD when compared to the overall population in Germany. 40 We used longitudinal data of Germany's second-largest insurance fund, BARMER, 

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical 109 Characterisation Protocol: prospective observational cohort study

Editor's Choice -Comorbidity 111

Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health 112 Insurance Claims Data

Editor´s Choice 114 -Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A 115 Propensity Score Matched Cohort Analysis

Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A 118 Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice 119 Guidelines

Influenza vaccination as 121 secondary prevention for cardiovascular disease: a science advisory from the

Association/American College of Cardiology